Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2003
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358322A2 A method of increasing complementarity in a heteroduplex polynucleotide
11/05/2003EP1358320A2 68730 and 69112 protein kinase molecules and uses therefor
11/05/2003EP1358318A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies
11/05/2003EP1358213A2 Humanized antibodies that recognize beta amyloid peptide
11/05/2003EP1357972A1 Electromagnetic set for , diagnostic, preventive, therapeutic purposes
11/05/2003EP1357941A2 Antagonists of myelin-associated glycoprotein and their use in the treatment and/or prevention of neurological diseases
11/05/2003EP1357940A2 Hepatitis b virus treatment
11/05/2003EP1203012B1 Refolding of membrane proteins using two different detergents
11/05/2003EP0912194B1 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease
11/05/2003EP0863991B1 Antigenic preparations
11/05/2003EP0713495B1 Methods of enhancing bioactivity of chemokines
11/05/2003EP0656061B1 Novel glycoforms of soluble complement receptor 1
11/05/2003EP0602248B1 screening of respiratory diseases throgh measurment of HUMAN LUNG SURFACTANT APOPROTEIN D
11/05/2003EP0489837B1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
11/05/2003EP0489058B1 Cystic fibrosis gene
11/05/2003CN1454257A Production of recombinant blood clotting factors in human cell lines
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1453294A Fusion and solubility expression of cobratoxin and acidolysis release and purification of recombinant toxin
11/05/2003CN1126818C Process for producing nucleic acid inhibiting protein by inducing and cultivating trichoid root of Chinese trichosanthes
11/04/2003US6642436 DNA encoding for plant digalactosyldiacylglycerol galactosyltransferase and methods of use
11/04/2003US6642371 Haemophilus adherence and penetration proteins
11/04/2003US6642369 Nucleic acids involved in the responder phenotype and applications thereof
11/04/2003US6642359 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease
11/04/2003US6642358 Receptor that binds trail
11/04/2003US6642354 Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes
11/04/2003US6642048 Conditioned media for propagating human pluripotent stem cells
11/04/2003US6642029 Yeast cells comprising vectors are joined to leader and processing signals which provide for expression and secretion of the gene product; Saccharomyces
11/04/2003US6642028 Isolated DNA encoding a Factor VIII protein; consensus splice sites which have been corrected relative to those of given nucleotide sequence
11/04/2003US6642027 Production of secreted polypeptides
11/04/2003US6642026 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
11/04/2003US6642025 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/04/2003US6642022 Polypeptide, encoded by recombinant nucleic acid; antagonists can be used for treatment of atherosclerosis and cancer; use for evaluating new drugs
11/04/2003US6642011 Reducing allegenic response heterologous proteins; obtain nucleotide sequences of heterologous protein, insert subtilisin sequences, transform cell, expression vector, recover protein, monitor human to protein
11/04/2003US6641997 Tetrameric, two-transmembrane-domain-type bound to a solid support; substituting amino acids to permit binding to agitoxin; use in treating cardiac arrhythmia, diabetes, seizures, asthma and hypertension
11/04/2003US6641812 Heat shock protein-based vaccines and immunotherapies
11/04/2003CA2084677C Apo ai polypeptides, antibodies, and immunoassays
11/04/2003CA2073616C Use of hpv-16 e6 and e7-gene derived peptides for the diagnostic purpose
11/01/2003CA2391438A1 Psp94 diagnostic reagents and assays
10/2003
10/30/2003WO2003089630A1 Methods for producing immortalised antibodies-secreting cells
10/30/2003WO2003089624A2 Fc receptor homolog, reagents, and uses thereof
10/30/2003WO2003089622A2 Novel genes, compositions, and methods for modulating the unfolded protein response
10/30/2003WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003WO2003089617A2 Methods for increasing homologous recombination of a nucleic acid sequence
10/30/2003WO2003089607A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003WO2003089603A2 Cytokine receptor
10/30/2003WO2003089571A2 Ehrlichia canis genes and vaccines
10/30/2003WO2003089455A2 Low-cost production of peptides
10/30/2003WO2003089454A2 Unnatural amino acid containing display libraries
10/30/2003WO2003088979A2 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof
10/30/2003WO2003088808A2 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003WO2003057919A3 The use of histamine h4 receptor antagonist for the treatment of inflammatory response
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003046004A3 Macroglobulin biopolymer markers indicative of insulin resistance
10/30/2003WO2003040310A3 Novel epidermal growth factor protein and gene, and methods of use therefor
10/30/2003WO2003037370A3 Anthrax antigenic compositions
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003004698A3 Method for monitoring and modulating protein folding
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2003000717A3 Identification of ses-3 (spr-5) in c. elegans and the uses of the same
10/30/2003WO2002094876A3 Methods and compositions for treating respiratory mucin production associated disease conditions
10/30/2003WO2002085941A3 Modified interferon alpha with reduced immunogenicity
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002062833A3 Modified leptin with reduced immunogenicity
10/30/2003WO2002059322A3 Compositions and methods relating to the daptomycin biosynthetic gene cluster
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002055704A3 Proteins, polynucleotides encoding them and methods of using the same
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002010414A9 Expression of biologically active polypeptides in duckweed
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003US20030204867 Nucleotide sequences coding transport protein for generating transgenic crop plants with adjusted nitrogen metabolism and which grow on acidic soils; increased biomass production
10/30/2003US20030204863 Nav2 channel gene-deficient non-human animals
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204060 Prepared by fermenting, incubating and eluting by washing with buffer, then chromatographing concentrated medium with lipophilic immobile phase comprising carrier coupled to 2-mercapto/hydroxyalkanoic acid
10/30/2003US20030204059 Preparing cytotoxic lymphocyte maturation factor (CLMF) from genetically engineered lymphoblastoid cells; for treating and preventing tumors and inflammation
10/30/2003US20030204054 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030204053 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203863 Interleukins (IL-2); cytokines; bovine growth hormone; cytomegalovirus; gene therapy
10/30/2003US20030203848 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline
10/30/2003US20030203842 Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203481 Miniaturized achromosomal, anucleotic, synthetic cells for use as diagnostics and drug disocovery tools in proteomics
10/30/2003US20030203464 Comprise Gtpase (RAC-GEF) polypeptide for treating diagnosis and treatment of cell proliferative disorders; antiproliferative agents
10/30/2003US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
10/30/2003US20030203462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203451 Interleukin-17 (IL-17)/G-protein coupled receptors protein for use in diagnosis and treatment of cell proliferative, bone and inflammatory disorders
10/30/2003US20030203448 Medium for the protein-free and serum-free cultivation of cells
10/30/2003US20030203447 Methods and materials for increasing expression of recombinant polypeptides
10/30/2003US20030203440 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203432 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
1 ... 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 ... 1125